Logo
MULTIPLE SCLEROSIS THERAPEUTICS MARKET ANALYSIS
  2. / Market Insights
  3. Multiple Sclerosis Therapeutics Market Analysis
all report title image

MULTIPLE SCLEROSIS THERAPEUTICS MARKET ANALYSIS

Multiple Sclerosis Therapeutics Market, By Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agent, Others), By Route of Administration (Oral, Injection, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI1310
  • Pages :148
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Multiple Sclerosis Therapeutics Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
    • Biogen Inc.
    • Novartis AG
    • Merck KGaA
    • Sanofi S. A.
    • Acorda Therapeutics, Inc.
    • Teva Pharmaceuticals Industries Ltd.
    • Bristol-Myers Squibb Company
    • Bayer AG
    • Hoffmann-La Roche AG
    • Viatris Inc. (Mylan NV)
    • Johnson & Johnson
    • EMD Serono, Inc.
    • TG Therapeutics, Inc.
    • Genentech, Inc.
    • Celgene Corporation
    • AbbVie Inc.
    • Amgen Inc.
    • UCB S.A.
    • Sandoz (a Novartis division)
    • Ipsen S.A.

    • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now

    Press Release

    Multiple Sclerosis Therapeutics Market to Surpass US$ 39.55 Bn by 2031
    Logo

    Credibility and Certifications

    ESOMAR
    DUNS Registered
    Clutch
    DMCA Protected

    9001:2015

    Credibility and Certifications

    27001:2022

    Credibility and Certifications

    EXISTING CLIENTELE

    Joining thousands of companies around the world committed to making the Excellent Business Solutions.

    View All Our Clients
    trusted clients logo
    © 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.